| Craig W Champion, DO | |
|
800 Washington St, Boston, MA 02111-1552 | |
| (617) 636-5000 | |
| Not Available |
| Full Name | Craig W Champion |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 20 Years |
| Location | 800 Washington St, Boston, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629251749 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 234750 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tufts Medical Center | Boston, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pratt Ob/gyn Associates, Inc | 9638060254 | 48 |
News Archive
Eric Brown, a professor and chair of the Department of Biochemistry and Biomedical Sciences, and a team of researchers from the Michael G. DeGroote Institute for Infectious Disease Research have identified a novel chemical compound that targets drug-resistant bacteria in a different way from existing antibiotics. The discovery could lead to new treatments to overcome antibiotic resistance in certain types of microorganisms.
Alpha Omega International Dental Fraternity honored Stanley M. Bergman, Chairman and Chief Executive Officer of Henry Schein, Inc., the largest distributor of health care products and services to office-based practitioners, at the Organization's 2010 Annual Sunny Days Convention.
A novel technology can make nanoscale protein measurements, which scientists can use in clinical trials to learn how drugs work.We are making progress toward the goal of understanding how drugs work in different individuals, said Alice C. Fan, M.D., instructor in the division of oncology at Stanford University School of Medicine.
An experimental medication safely increases muscle strength and physical functioning among cancer patients with low testosterone levels, a new drug study finds. The results will be presented Sunday at The Endocrine Society's 94th Annual Meeting in Houston.
With a $3 million annual commitment to support promising blood disease research amid limited National Institutes of Health funding, the American Society of Hematology-the world's largest professional society concerned with the causes and treatment of blood disorders-today announced the formal establishment of the ASH Bridge Grant program after an extended four-year pilot study.
› Verified 4 days ago
| Entity Name | Harbor Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881692366 PECOS PAC ID: 0345146213 Enrollment ID: O20040223000221 |
News Archive
Eric Brown, a professor and chair of the Department of Biochemistry and Biomedical Sciences, and a team of researchers from the Michael G. DeGroote Institute for Infectious Disease Research have identified a novel chemical compound that targets drug-resistant bacteria in a different way from existing antibiotics. The discovery could lead to new treatments to overcome antibiotic resistance in certain types of microorganisms.
Alpha Omega International Dental Fraternity honored Stanley M. Bergman, Chairman and Chief Executive Officer of Henry Schein, Inc., the largest distributor of health care products and services to office-based practitioners, at the Organization's 2010 Annual Sunny Days Convention.
A novel technology can make nanoscale protein measurements, which scientists can use in clinical trials to learn how drugs work.We are making progress toward the goal of understanding how drugs work in different individuals, said Alice C. Fan, M.D., instructor in the division of oncology at Stanford University School of Medicine.
An experimental medication safely increases muscle strength and physical functioning among cancer patients with low testosterone levels, a new drug study finds. The results will be presented Sunday at The Endocrine Society's 94th Annual Meeting in Houston.
With a $3 million annual commitment to support promising blood disease research amid limited National Institutes of Health funding, the American Society of Hematology-the world's largest professional society concerned with the causes and treatment of blood disorders-today announced the formal establishment of the ASH Bridge Grant program after an extended four-year pilot study.
› Verified 4 days ago
| Entity Name | Pratt Ob/gyn Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336186501 PECOS PAC ID: 9638060254 Enrollment ID: O20040323001130 |
News Archive
Eric Brown, a professor and chair of the Department of Biochemistry and Biomedical Sciences, and a team of researchers from the Michael G. DeGroote Institute for Infectious Disease Research have identified a novel chemical compound that targets drug-resistant bacteria in a different way from existing antibiotics. The discovery could lead to new treatments to overcome antibiotic resistance in certain types of microorganisms.
Alpha Omega International Dental Fraternity honored Stanley M. Bergman, Chairman and Chief Executive Officer of Henry Schein, Inc., the largest distributor of health care products and services to office-based practitioners, at the Organization's 2010 Annual Sunny Days Convention.
A novel technology can make nanoscale protein measurements, which scientists can use in clinical trials to learn how drugs work.We are making progress toward the goal of understanding how drugs work in different individuals, said Alice C. Fan, M.D., instructor in the division of oncology at Stanford University School of Medicine.
An experimental medication safely increases muscle strength and physical functioning among cancer patients with low testosterone levels, a new drug study finds. The results will be presented Sunday at The Endocrine Society's 94th Annual Meeting in Houston.
With a $3 million annual commitment to support promising blood disease research amid limited National Institutes of Health funding, the American Society of Hematology-the world's largest professional society concerned with the causes and treatment of blood disorders-today announced the formal establishment of the ASH Bridge Grant program after an extended four-year pilot study.
› Verified 4 days ago
| Entity Name | Vhm Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508818618 PECOS PAC ID: 4183637929 Enrollment ID: O20060724000131 |
News Archive
Eric Brown, a professor and chair of the Department of Biochemistry and Biomedical Sciences, and a team of researchers from the Michael G. DeGroote Institute for Infectious Disease Research have identified a novel chemical compound that targets drug-resistant bacteria in a different way from existing antibiotics. The discovery could lead to new treatments to overcome antibiotic resistance in certain types of microorganisms.
Alpha Omega International Dental Fraternity honored Stanley M. Bergman, Chairman and Chief Executive Officer of Henry Schein, Inc., the largest distributor of health care products and services to office-based practitioners, at the Organization's 2010 Annual Sunny Days Convention.
A novel technology can make nanoscale protein measurements, which scientists can use in clinical trials to learn how drugs work.We are making progress toward the goal of understanding how drugs work in different individuals, said Alice C. Fan, M.D., instructor in the division of oncology at Stanford University School of Medicine.
An experimental medication safely increases muscle strength and physical functioning among cancer patients with low testosterone levels, a new drug study finds. The results will be presented Sunday at The Endocrine Society's 94th Annual Meeting in Houston.
With a $3 million annual commitment to support promising blood disease research amid limited National Institutes of Health funding, the American Society of Hematology-the world's largest professional society concerned with the causes and treatment of blood disorders-today announced the formal establishment of the ASH Bridge Grant program after an extended four-year pilot study.
› Verified 4 days ago
| Entity Name | Lgh Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174698385 PECOS PAC ID: 3173626751 Enrollment ID: O20070320000453 |
News Archive
Eric Brown, a professor and chair of the Department of Biochemistry and Biomedical Sciences, and a team of researchers from the Michael G. DeGroote Institute for Infectious Disease Research have identified a novel chemical compound that targets drug-resistant bacteria in a different way from existing antibiotics. The discovery could lead to new treatments to overcome antibiotic resistance in certain types of microorganisms.
Alpha Omega International Dental Fraternity honored Stanley M. Bergman, Chairman and Chief Executive Officer of Henry Schein, Inc., the largest distributor of health care products and services to office-based practitioners, at the Organization's 2010 Annual Sunny Days Convention.
A novel technology can make nanoscale protein measurements, which scientists can use in clinical trials to learn how drugs work.We are making progress toward the goal of understanding how drugs work in different individuals, said Alice C. Fan, M.D., instructor in the division of oncology at Stanford University School of Medicine.
An experimental medication safely increases muscle strength and physical functioning among cancer patients with low testosterone levels, a new drug study finds. The results will be presented Sunday at The Endocrine Society's 94th Annual Meeting in Houston.
With a $3 million annual commitment to support promising blood disease research amid limited National Institutes of Health funding, the American Society of Hematology-the world's largest professional society concerned with the causes and treatment of blood disorders-today announced the formal establishment of the ASH Bridge Grant program after an extended four-year pilot study.
› Verified 4 days ago
| Entity Name | Circle Health Obgyn, Llc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912179870 PECOS PAC ID: 1052483476 Enrollment ID: O20080630000642 |
News Archive
Eric Brown, a professor and chair of the Department of Biochemistry and Biomedical Sciences, and a team of researchers from the Michael G. DeGroote Institute for Infectious Disease Research have identified a novel chemical compound that targets drug-resistant bacteria in a different way from existing antibiotics. The discovery could lead to new treatments to overcome antibiotic resistance in certain types of microorganisms.
Alpha Omega International Dental Fraternity honored Stanley M. Bergman, Chairman and Chief Executive Officer of Henry Schein, Inc., the largest distributor of health care products and services to office-based practitioners, at the Organization's 2010 Annual Sunny Days Convention.
A novel technology can make nanoscale protein measurements, which scientists can use in clinical trials to learn how drugs work.We are making progress toward the goal of understanding how drugs work in different individuals, said Alice C. Fan, M.D., instructor in the division of oncology at Stanford University School of Medicine.
An experimental medication safely increases muscle strength and physical functioning among cancer patients with low testosterone levels, a new drug study finds. The results will be presented Sunday at The Endocrine Society's 94th Annual Meeting in Houston.
With a $3 million annual commitment to support promising blood disease research amid limited National Institutes of Health funding, the American Society of Hematology-the world's largest professional society concerned with the causes and treatment of blood disorders-today announced the formal establishment of the ASH Bridge Grant program after an extended four-year pilot study.
› Verified 4 days ago
| Entity Name | Steward Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629398219 PECOS PAC ID: 2860688728 Enrollment ID: O20101119000332 |
News Archive
Eric Brown, a professor and chair of the Department of Biochemistry and Biomedical Sciences, and a team of researchers from the Michael G. DeGroote Institute for Infectious Disease Research have identified a novel chemical compound that targets drug-resistant bacteria in a different way from existing antibiotics. The discovery could lead to new treatments to overcome antibiotic resistance in certain types of microorganisms.
Alpha Omega International Dental Fraternity honored Stanley M. Bergman, Chairman and Chief Executive Officer of Henry Schein, Inc., the largest distributor of health care products and services to office-based practitioners, at the Organization's 2010 Annual Sunny Days Convention.
A novel technology can make nanoscale protein measurements, which scientists can use in clinical trials to learn how drugs work.We are making progress toward the goal of understanding how drugs work in different individuals, said Alice C. Fan, M.D., instructor in the division of oncology at Stanford University School of Medicine.
An experimental medication safely increases muscle strength and physical functioning among cancer patients with low testosterone levels, a new drug study finds. The results will be presented Sunday at The Endocrine Society's 94th Annual Meeting in Houston.
With a $3 million annual commitment to support promising blood disease research amid limited National Institutes of Health funding, the American Society of Hematology-the world's largest professional society concerned with the causes and treatment of blood disorders-today announced the formal establishment of the ASH Bridge Grant program after an extended four-year pilot study.
› Verified 4 days ago
| Entity Name | Obhg Massachusetts Lowell Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861036451 PECOS PAC ID: 0244667574 Enrollment ID: O20200227000344 |
News Archive
Eric Brown, a professor and chair of the Department of Biochemistry and Biomedical Sciences, and a team of researchers from the Michael G. DeGroote Institute for Infectious Disease Research have identified a novel chemical compound that targets drug-resistant bacteria in a different way from existing antibiotics. The discovery could lead to new treatments to overcome antibiotic resistance in certain types of microorganisms.
Alpha Omega International Dental Fraternity honored Stanley M. Bergman, Chairman and Chief Executive Officer of Henry Schein, Inc., the largest distributor of health care products and services to office-based practitioners, at the Organization's 2010 Annual Sunny Days Convention.
A novel technology can make nanoscale protein measurements, which scientists can use in clinical trials to learn how drugs work.We are making progress toward the goal of understanding how drugs work in different individuals, said Alice C. Fan, M.D., instructor in the division of oncology at Stanford University School of Medicine.
An experimental medication safely increases muscle strength and physical functioning among cancer patients with low testosterone levels, a new drug study finds. The results will be presented Sunday at The Endocrine Society's 94th Annual Meeting in Houston.
With a $3 million annual commitment to support promising blood disease research amid limited National Institutes of Health funding, the American Society of Hematology-the world's largest professional society concerned with the causes and treatment of blood disorders-today announced the formal establishment of the ASH Bridge Grant program after an extended four-year pilot study.
› Verified 4 days ago
| Entity Name | Obhg Massachusetts - Direct Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487229035 PECOS PAC ID: 1456752609 Enrollment ID: O20210625001903 |
News Archive
Eric Brown, a professor and chair of the Department of Biochemistry and Biomedical Sciences, and a team of researchers from the Michael G. DeGroote Institute for Infectious Disease Research have identified a novel chemical compound that targets drug-resistant bacteria in a different way from existing antibiotics. The discovery could lead to new treatments to overcome antibiotic resistance in certain types of microorganisms.
Alpha Omega International Dental Fraternity honored Stanley M. Bergman, Chairman and Chief Executive Officer of Henry Schein, Inc., the largest distributor of health care products and services to office-based practitioners, at the Organization's 2010 Annual Sunny Days Convention.
A novel technology can make nanoscale protein measurements, which scientists can use in clinical trials to learn how drugs work.We are making progress toward the goal of understanding how drugs work in different individuals, said Alice C. Fan, M.D., instructor in the division of oncology at Stanford University School of Medicine.
An experimental medication safely increases muscle strength and physical functioning among cancer patients with low testosterone levels, a new drug study finds. The results will be presented Sunday at The Endocrine Society's 94th Annual Meeting in Houston.
With a $3 million annual commitment to support promising blood disease research amid limited National Institutes of Health funding, the American Society of Hematology-the world's largest professional society concerned with the causes and treatment of blood disorders-today announced the formal establishment of the ASH Bridge Grant program after an extended four-year pilot study.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Craig W Champion, DO 300 Congress St, Suite 102, Quincy, MA 02169-0907 Ph: (617) 479-6636 | Craig W Champion, DO 800 Washington St, Boston, MA 02111-1552 Ph: (617) 636-5000 |
News Archive
Eric Brown, a professor and chair of the Department of Biochemistry and Biomedical Sciences, and a team of researchers from the Michael G. DeGroote Institute for Infectious Disease Research have identified a novel chemical compound that targets drug-resistant bacteria in a different way from existing antibiotics. The discovery could lead to new treatments to overcome antibiotic resistance in certain types of microorganisms.
Alpha Omega International Dental Fraternity honored Stanley M. Bergman, Chairman and Chief Executive Officer of Henry Schein, Inc., the largest distributor of health care products and services to office-based practitioners, at the Organization's 2010 Annual Sunny Days Convention.
A novel technology can make nanoscale protein measurements, which scientists can use in clinical trials to learn how drugs work.We are making progress toward the goal of understanding how drugs work in different individuals, said Alice C. Fan, M.D., instructor in the division of oncology at Stanford University School of Medicine.
An experimental medication safely increases muscle strength and physical functioning among cancer patients with low testosterone levels, a new drug study finds. The results will be presented Sunday at The Endocrine Society's 94th Annual Meeting in Houston.
With a $3 million annual commitment to support promising blood disease research amid limited National Institutes of Health funding, the American Society of Hematology-the world's largest professional society concerned with the causes and treatment of blood disorders-today announced the formal establishment of the ASH Bridge Grant program after an extended four-year pilot study.
› Verified 4 days ago
Sheela S Maru, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 850 Harrison Ave, Yacc 4, Boston, MA 02118 Phone: 617-414-2000 Fax: 617-414-5798 | |
Dr. Devon Abt Harris, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 330 Brookline Ave # Shapiro8, Boston, MA 02215 Phone: 617-667-3736 Fax: 617-667-7493 | |
Maureen E Paul, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1055 Commonwealth Ave, Boston, MA 02215 Phone: 917-208-9521 | |
Charles-chidi W Obasiolu, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: Ctr For Fertility & Repro Hlth, 133 Brookline Ave, Boston, MA 02215 Phone: 617-421-2987 Fax: 617-421-2989 | |
Dr. Erik M Clinton, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 750 Washington St, Boston, MA 02111 Phone: 617-636-5000 | |
Evelyn Hall, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 800 Washington St, Boston, MA 02111 Phone: 269-552-8685 | |
Toni Beth Walzer, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 333 Longwood Avenue, Adolescent Gynecology, Boston, MA 02115 Phone: 617-355-5785 |